ArticleNeuropsychiatric disease and treatment2023

Efficacy and Safety of Paliperidone Palmitate 6-Month versus Paliperidone Palmitate 3-Month Long-Acting Injectable in European Patients with Schizophrenia: A Post Hoc Analysis of a Global Phase-3 Double-Blind Randomized Non-Inferiority Study.

Cesar Giron-Hernandez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.